Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W-135 Combined (Sanofi Pasteur)

A, C, Y, W-135群脑膜炎球菌多糖联合疫苗 （赛诺菲巴斯德）

Report date: 2022/09/08 17:19:48

Base Information

Drug NameMeningococcal Polysaccharide Vaccine, Groups A, C, Y, W-135 Combined (Sanofi Pasteur)
Drug Alias NameMenomune-A/C/Y/W-135
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningococcal Infections
Global Approved IndicationsMeningococcal Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1981/11/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMeningococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH04
Related LinksN/A